A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Factor V Leiden (FVL) is a change in your genes that affects one of the clotting factors in your blood and keeps your body's blood-clotting process from working right. It can cause a disorder called ...